|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2009-11-30
|
|
pubmed:abstractText |
Cytomegalovirus (CMV) infection has been implicated in a number of complications after heart transplantation. A recent study suggested that children with positive CMV serology (CMV(+)) before transplantation are at increased risk of developing coronary allograft vasculopathy (CAV) and death when compared with CMV(-) recipients. We analyzed data from the Pediatric Heart Transplant Study Group to determine the impact of recipient CMV status and CMV mismatching on outcome. In addition, the use and efficacy of CMV prophylaxis were studied.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1557-3117
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1299-305
|
|
pubmed:meshHeading |
pubmed-meshheading:19783178-Antibodies, Viral,
pubmed-meshheading:19783178-Child,
pubmed-meshheading:19783178-Cytomegalovirus,
pubmed-meshheading:19783178-Cytomegalovirus Infections,
pubmed-meshheading:19783178-Female,
pubmed-meshheading:19783178-Follow-Up Studies,
pubmed-meshheading:19783178-Heart Transplantation,
pubmed-meshheading:19783178-Humans,
pubmed-meshheading:19783178-Incidence,
pubmed-meshheading:19783178-Male,
pubmed-meshheading:19783178-Prognosis,
pubmed-meshheading:19783178-Retrospective Studies,
pubmed-meshheading:19783178-Risk Factors,
pubmed-meshheading:19783178-Survival Rate,
pubmed-meshheading:19783178-United States
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Does cytomegalovirus serology impact outcome after pediatric heart transplantation?
|
|
pubmed:affiliation |
Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia 30322-1062, USA. wmahle@emory.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
